Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor 32Unspecified Adult Solid Tumor, Protocol Specific 28Hematopoietic and Lymphatic System Neoplasm 28Mesothelioma 24Mesothelioma, Malignant 23Solid Tumor, Adult 19Retinoblastoma 17Hematopoietic and Lymphoid System Neoplasm 15Carcinoma, Non-Small-Cell Lung 9Malignant Solid Neoplasm 8Lung Neoplasms 8Solid Tumors 7Small Cell Lung Carcinoma 6Refractory Solid Tumors 5Advanced Malignant Solid Neoplasm 5Pancreatic Neoplasms 4Advanced Solid Tumors 4Advanced Solid Tumor 4Unspecified Childhood Solid Tumor, Protocol Specific 3Solid Tumor Cancer 3Psychosocial Effects of Cancer and Its Treatment 3Prostatic Neoplasms 3Pleural Effusion 3Esophageal Neoplasms 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Breast Neoplasms 3Advanced Malignant Solid Tumors 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Dermatologic Complications × Other solid neoplasm × Clear all
NCT00498992 2013-09-20

Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer

National Cancer Institute (NCI)

Phase NA Unknown
20 enrolled
Other solid neoplasm

Dermatologic Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡